Who are Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Amoxil, Bicillin C-R, Bicillin C-R, Amoxicillin (ST14), Single Agent IV Antibiotic Therapy - MSSA, anti-pseudomonal penicillin.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/piperacillin-tazobactam-amoxicillin-clavulanic-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid (Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Beta-lactam antibiotic. Area: Infectious Diseases.

phase 3 Beta-lactam antibiotic Infectious Diseases Small molecule Live · refreshed every 30 min

Target snapshot

Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid (Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid) — Bayer. Piperacillin/Tazobactam is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis, while Amoxicillin/Clavulanic acid is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis and is protected from beta-lactamase degradation by Clavulanic acid.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid TARGET	Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid	Bayer	phase 3	Beta-lactam antibiotic
Amoxil	amoxicillin	Generic (originally Beecham/GSK)	marketed	Aminopenicillin (Beta-lactam antibiotic)	5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C	1972-01-01
Bicillin C-R	Penicillin G Benzathine	Pfizer	marketed	Beta-lactam antibiotic	Cell-wall peptidoglycan biosynthesis	1952-01-01
Bicillin C-R	Penicillin G Benzathine	Pfizer	marketed	Beta-lactam antibiotic	Cell-wall peptidoglycan biosynthesis	1952-01-01
Amoxicillin (ST14)	Amoxicillin (ST14)	National Taiwan University Hospital	marketed	Beta-lactam antibiotic	Penicillin-binding proteins (PBPs)
Single Agent IV Antibiotic Therapy - MSSA	Single Agent IV Antibiotic Therapy - MSSA	West Virginia University	marketed	Beta-lactam antibiotic	Penicillin-binding proteins (PBPs); bacterial cell wall peptidoglycan
anti-pseudomonal penicillin	anti-pseudomonal penicillin	Vanderbilt University Medical Center	marketed	Beta-lactam antibiotic (anti-pseudomonal penicillin)	Penicillin-binding proteins (PBPs); bacterial cell wall peptidoglycan

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2026-12-08 — Amoxil · 8778924 · Compound · US
2026-12-08 — Amoxil · 8357394 · Formulation · US
2027-05-07 — Amoxil · 8299052 · Method of Use · US

Sponsor landscape (Beta-lactam antibiotic class)

Pfizer · 2 drugs in this class
Bayer · 1 drug in this class
Belén Retamal-Valdes · 1 drug in this class
Benova (Tianjin) Innovative medicine Research Co., Ltd. · 1 drug in this class
Esraa Salah Mohamed Abdallah Eladl · 1 drug in this class
Incheon St.Mary's Hospital · 1 drug in this class
International Maternal Pediatric Adolescent AIDS Clinical Trials Group · 1 drug in this class
KEMRI-Wellcome Trust Collaborative Research Program · 1 drug in this class
National Taiwan University Hospital · 1 drug in this class
Pfizer Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/piperacillin-tazobactam-amoxicillin-clavulanic-acid. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab